Elevance Health, Inc. SEC filings ELV

Elevance Health, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Nov 21, 2013. Its latest annual report, Form 10-K, was filed on Feb 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 21, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (results of operations). The company's fiscal year ends on December 31.

Elevance Health, Inc. SEC filings
Form Description Filed Period
S-3ASR Automatic shelf registration Oct 28, 2026 —
10-Q Quarterly report Oct 21, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 21, 2026 Oct 21, 2026
8-K Current report
Regulation FD disclosure
Sep 10, 2026 Sep 10, 2026
10-Q Quarterly report Jul 15, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 15, 2026 Jul 15, 2026
11-K Employee savings plan report Jun 17, 2026 Dec 31, 2025
11-K Employee savings plan report Jun 17, 2026 Dec 31, 2025
8-K Current report
Regulation FD disclosure
Jun 10, 2026 Jun 10, 2026
8-K Current report
Shareholder vote results
May 13, 2026 May 13, 2026
10-Q Quarterly report Apr 22, 2026 Mar 31, 2026
8-K Current report
Results of operations
Apr 22, 2026 Apr 22, 2026
PX14A6G Filing Apr 7, 2026 —
DEFA14A Additional proxy material Mar 27, 2026 —
DEF 14A Proxy statement Mar 27, 2026 May 13, 2026
8-K Current report
Regulation FD disclosure
Mar 10, 2026 Mar 10, 2026
8-K Current report
Other events
Mar 2, 2026 Mar 2, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 26, 2026 Feb 26, 2026
10-K Annual report Feb 6, 2026 Dec 31, 2025
8-K Current report
Results of operations
Jan 28, 2026 Jan 28, 2026
8-K Current report
Officer or director change
Dec 10, 2025 Dec 10, 2025
8-K Current report
Regulation FD disclosure
Nov 10, 2025 Nov 10, 2025
10-Q Quarterly report Oct 21, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 21, 2025 Oct 21, 2025
8-K Current report
Other events
Sep 15, 2025 Sep 8, 2025
424B3 Prospectus Sep 9, 2025 —
FWP Free writing prospectus Sep 8, 2025 —
424B3 Prospectus Sep 8, 2025 —
8-K Current report
Regulation FD disclosure
Sep 4, 2025 Sep 4, 2025
8-K Current report
Officer or director change
Jul 28, 2025 Jul 28, 2025
10-Q Quarterly report Jul 17, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 17, 2025 Jul 17, 2025
11-K Employee savings plan report Jun 24, 2025 Dec 31, 2024
11-K Employee savings plan report Jun 24, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure
May 28, 2025 May 28, 2025
8-K Current report
Shareholder vote results
May 14, 2025 May 14, 2025
10-Q Quarterly report Apr 22, 2025 Mar 31, 2025
8-K Current report
Results of operations
Apr 22, 2025 Apr 22, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Apr 17, 2025 Apr 17, 2025
PX14A6G Filing Apr 14, 2025 —
DEFA14A Additional proxy material Mar 28, 2025 —
DEFA14A Additional proxy material Mar 28, 2025 —
DEF 14A Proxy statement Mar 28, 2025 May 14, 2025
8-K Current report
Regulation FD disclosure
Mar 10, 2025 Mar 10, 2025
10-K Annual report Feb 20, 2025 Dec 31, 2024
8-K Current report
Results of operations
Jan 23, 2025 Jan 23, 2025
8-K Current report
Other events
Oct 31, 2024 Oct 22, 2024
424B3 Prospectus Oct 23, 2024 —
FWP Free writing prospectus Oct 22, 2024 —
424B3 Prospectus Oct 22, 2024 —
10-Q Quarterly report Oct 17, 2024 Sep 30, 2024
8-K Current report
Results of operations
Oct 17, 2024 Oct 17, 2024
10-Q Quarterly report Jul 17, 2024 Jun 30, 2024
8-K Current report
Results of operations
Jul 17, 2024 Jul 17, 2024
11-K Employee savings plan report Jun 20, 2024 Dec 31, 2023
8-K Current report
Regulation FD disclosure
Jun 12, 2024 Jun 12, 2024
8-K Current report
Other events
May 30, 2024 May 20, 2024
424B3 Prospectus May 21, 2024 —
FWP Free writing prospectus May 20, 2024 —
424B3 Prospectus May 20, 2024 —
8-K Current report
Shareholder vote results
May 15, 2024 May 15, 2024
DEFA14A Additional proxy material Apr 22, 2024 —
10-Q Quarterly report Apr 18, 2024 Mar 31, 2024
8-K Current report
Results of operations
Apr 18, 2024 Apr 18, 2024
DEFA14A Additional proxy material Mar 29, 2024 —
DEF 14A Proxy statement Mar 29, 2024 May 15, 2024
8-K Current report
Regulation FD disclosure
Mar 4, 2024 Mar 4, 2024
S-8 Employee stock plan registration Feb 23, 2024 —
10-K Annual report Feb 21, 2024 Dec 31, 2023
8-K Current report
Other events
Jan 25, 2024 Jan 23, 2024
8-K Current report
Results of operations
Jan 24, 2024 Jan 24, 2024
S-3ASR Automatic shelf registration Nov 1, 2023 —
10-Q Quarterly report Oct 18, 2023 Sep 30, 2023
8-K Current report
Results of operations
Oct 18, 2023 Oct 18, 2023
8-K Current report
Regulation FD disclosure
Oct 13, 2023 Oct 13, 2023
8-K Current report
Bylaw or fiscal year change
Oct 5, 2023 Oct 4, 2023
10-Q/A Amended quarterly report Sep 29, 2023 Jun 30, 2023
8-K Current report
Regulation FD disclosure
Sep 20, 2023 Sep 20, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 8, 2023 Aug 2, 2023
10-Q Quarterly report Jul 19, 2023 Jun 30, 2023
8-K Current report
Results of operations
Jul 19, 2023 Jul 19, 2023
11-K Employee savings plan report Jun 22, 2023 Dec 31, 2022
8-K Current report
Regulation FD disclosure
Jun 13, 2023 Jun 13, 2023
8-K Current report
Shareholder vote results
May 11, 2023 May 10, 2023
10-Q Quarterly report Apr 19, 2023 Mar 31, 2023
8-K Current report
Results of operations
Apr 19, 2023 Apr 19, 2023
DEFA14A Additional proxy material Mar 31, 2023 —
DEF 14A Proxy statement Mar 31, 2023 —
8-K Current report
Regulation FD disclosure
Mar 22, 2023 Mar 22, 2023
8-K Current report
Officer or director change
Feb 22, 2023 Feb 15, 2023
10-K Annual report Feb 15, 2023 Dec 31, 2022
8-K Current report
Other events
Feb 8, 2023 Jan 30, 2023
424B3 Prospectus Feb 1, 2023 —
FWP Free writing prospectus Jan 30, 2023 —
424B3 Prospectus Jan 30, 2023 —
8-K Current report
Results of operations
Jan 25, 2023 Jan 25, 2023
8-K Current report
Other events
Nov 4, 2022 Oct 26, 2022
424B3 Prospectus Oct 27, 2022 —
FWP Free writing prospectus Oct 26, 2022 —
424B3 Prospectus Oct 26, 2022 —
8-K Current report
Officer or director change
Oct 25, 2022 Oct 24, 2022
10-Q Quarterly report Oct 19, 2022 Sep 30, 2022
8-K Current report
Results of operations
Oct 19, 2022 Oct 19, 2022
10-Q Quarterly report Jul 20, 2022 Jun 30, 2022
8-K Current report
Results of operations
Jul 20, 2022 Jul 20, 2022
8-K Current report
Bylaw or fiscal year change
Jun 28, 2022 Jun 27, 2022
11-K Employee savings plan report Jun 24, 2022 Dec 31, 2021
8-K Current report
Regulation FD disclosure
Jun 2, 2022 Jun 2, 2022
8-K Current report
Shareholder vote results
May 19, 2022 May 18, 2022
DEFA14A Additional proxy material May 6, 2022 —
8-K Current report
Other events
Apr 29, 2022 Apr 26, 2022
424B3 Prospectus Apr 28, 2022 —
FWP Free writing prospectus Apr 26, 2022 —
424B3 Prospectus Apr 26, 2022 —
8-K/A Amended current report
Results of operations
Apr 22, 2022 Apr 20, 2022
10-Q Quarterly report Apr 20, 2022 Mar 31, 2022
8-K Current report
Acquisition or sale of assets
Apr 20, 2022 Apr 20, 2022
DEFA14A Additional proxy material Apr 1, 2022 —
DEF 14A Proxy statement Apr 1, 2022 May 18, 2022
PRE 14A Preliminary proxy statement Mar 11, 2022 Dec 31, 2021
8-K Current report
Regulation FD disclosure
Mar 8, 2022 Mar 8, 2022
10-K Annual report Feb 16, 2022 Dec 31, 2021
8-K Current report
Results of operations
Jan 26, 2022 Jan 26, 2022
10-Q Quarterly report Oct 20, 2021 Sep 30, 2021
8-K Current report
Results of operations
Oct 20, 2021 Oct 20, 2021
8-K Current report
Regulation FD disclosure
Sep 8, 2021 Sep 8, 2021
8-K Current report
Officer or director change
Aug 4, 2021 Aug 3, 2021
10-Q Quarterly report Jul 21, 2021 Jun 30, 2021
8-K Current report
Results of operations
Jul 21, 2021 Jul 21, 2021
11-K Employee savings plan report Jun 29, 2021 Dec 31, 2020
8-K Current report
Regulation FD disclosure
Jun 4, 2021 Jun 4, 2021
8-K Current report
Shareholder vote results
May 27, 2021 May 26, 2021
10-Q Quarterly report Apr 21, 2021 Mar 31, 2021
8-K Current report
Results of operations
Apr 21, 2021 Apr 21, 2021
DEFA14A Additional proxy material Apr 9, 2021 —
DEF 14A Proxy statement Apr 9, 2021 May 26, 2021
8-K Current report
Other events
Mar 17, 2021 Mar 8, 2021
424B3 Prospectus Mar 10, 2021 —
FWP Free writing prospectus Mar 9, 2021 —
424B3 Prospectus Mar 8, 2021 —
8-K Current report
Regulation FD disclosure
Mar 2, 2021 Mar 2, 2021
10-K Annual report Feb 18, 2021 Dec 31, 2020
8-K Current report
Results of operations
Jan 27, 2021 Jan 27, 2021
S-3ASR Automatic shelf registration Nov 5, 2020 —
10-Q Quarterly report Oct 28, 2020 Sep 30, 2020
8-K Current report
Results of operations
Oct 28, 2020 Oct 28, 2020
8-K Current report
Bylaw or fiscal year change
Oct 6, 2020 Sep 30, 2020
10-Q Quarterly report Jul 29, 2020 Jun 30, 2020
8-K Current report
Results of operations
Jul 29, 2020 Jul 29, 2020
11-K Employee savings plan report Jun 29, 2020 Dec 31, 2019
8-K Current report
Regulation FD disclosure
Jun 9, 2020 Jun 9, 2020
8-K Current report
Shareholder vote results
May 21, 2020 May 21, 2020
8-K Current report
Other events
May 5, 2020 Apr 30, 2020
424B3 Prospectus May 4, 2020 —
FWP Free writing prospectus Apr 30, 2020 —
424B3 Prospectus Apr 30, 2020 —
10-Q Quarterly report Apr 29, 2020 Mar 31, 2020
8-K Current report
Results of operations
Apr 29, 2020 Apr 29, 2020
DEFA14A Additional proxy material Apr 17, 2020 —
8-K Current report
Bylaw or fiscal year change
Apr 8, 2020 Apr 8, 2020
DEFA14A Additional proxy material Mar 27, 2020 —
DEF 14A Proxy statement Mar 27, 2020 May 21, 2020
8-K Current report
Regulation FD disclosure
Mar 9, 2020 Mar 9, 2020
10-K Annual report Feb 19, 2020 Dec 31, 2019
8-K Current report
Results of operations
Jan 29, 2020 Jan 29, 2020
10-Q Quarterly report Oct 23, 2019 Sep 30, 2019
8-K Current report
Results of operations
Oct 23, 2019 Oct 23, 2019
8-K Current report
Officer or director change
Oct 1, 2019 Oct 1, 2019
8-K Current report
Regulation FD disclosure
Sep 16, 2019 Sep 16, 2019
8-K Current report
Other events
Sep 9, 2019 Sep 4, 2019
424B5 Prospectus supplement Sep 6, 2019 —
FWP Free writing prospectus Sep 5, 2019 —
424B3 Prospectus Sep 4, 2019 —
10-Q Quarterly report Jul 24, 2019 Jun 30, 2019
8-K Current report
Results of operations
Jul 24, 2019 Jul 24, 2019
11-K Employee savings plan report Jun 27, 2019 Dec 31, 2018
8-K Current report
Regulation FD disclosure
Jun 17, 2019 Jun 17, 2019
8-K/A Amended current report
Bylaw or fiscal year change
Jun 5, 2019 May 15, 2019
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
May 15, 2019 May 15, 2019
10-Q Quarterly report Apr 24, 2019 Mar 31, 2019
8-K Current report
Results of operations
Apr 24, 2019 Apr 24, 2019
DEFA14A Additional proxy material Mar 29, 2019 —
DEF 14A Proxy statement Mar 29, 2019 May 15, 2019
PRE 14A Preliminary proxy statement Mar 14, 2019 May 15, 2019
8-K Current report
Regulation FD disclosure
Mar 6, 2019 Mar 6, 2019
10-K Annual report Feb 20, 2019 Dec 31, 2018
8-K Current report
Results of operations, Regulation FD disclosure
Jan 30, 2019 Jan 30, 2019
8-K Current report
Regulation FD disclosure
Nov 29, 2018 Nov 29, 2018
10-Q Quarterly report Oct 31, 2018 Sep 30, 2018
8-K Current report
Results of operations
Oct 31, 2018 Oct 31, 2018
8-K Current report
Regulation FD disclosure
Sep 12, 2018 Sep 12, 2018
10-Q Quarterly report Jul 25, 2018 Jun 30, 2018
8-K Current report
Results of operations
Jul 25, 2018 Jul 25, 2018
11-K Employee savings plan report Jun 15, 2018 Dec 31, 2017
8-K Current report
Regulation FD disclosure
Jun 13, 2018 Jun 13, 2018
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
May 16, 2018 May 16, 2018
8-K Current report
Officer or director change
May 10, 2018 May 8, 2018
25-NSE Delisting notice May 1, 2018 —
10-Q Quarterly report Apr 25, 2018 Mar 31, 2018
8-K Current report
Results of operations
Apr 25, 2018 Apr 25, 2018

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Hospital & Medical Service Plans (SIC 6324)
Listed as
ELV (NYSE)
Fiscal year ends
December 31
Incorporated in
IN
Headquarters
Indianapolis, IN
SEC filer status
Large accelerated filer
SEC CIK
1156039
Former names
Anthem, Inc. (until Jun 24, 2022); WELLPOINT, INC (until Nov 12, 2014); WELLPOINT INC (until Dec 21, 2009); ANTHEM INC (until Nov 30, 2004)

Other Hospital & Medical Service Plans companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.